Stock Events

Stock Events

Acrivon Therapeutics (ACRV) Q4 2023 Earnings

28MarConfirmed

Q1 2023

Q2 2023

Q3 2023

Q4 2023

-0.86

-0.57

-0.29

0

Details

Expected EPS

-0.73

Actual EPS

-0.86

Surprise EPS

-0.13

Surprise Percent

+17.81%

Description

Acrivon Therapeutics (ACRV) has reported earnings of -0.86 per share for Q4 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.